RBC Life Science and Technology Fund

You are on: FUND INDIVIDUAL page

Select Series:
Select Another Fund:

Marcello Montanari

Profile >

Rob Cavallo

Profile >

Investment Objective

To provide long-term capital growth by investing primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.

Fund Details

Series: A
Fund Code: RBF274
Load Structure: No Load
Currency: CAD
Inception Date: Jul, 1995
Series A NAV $: 17.87
Series A MER %: 2.09
  • 50% S&P 500 Health Care Index ($C)
  • 50% S&P 500 Information Technology Index ($C)

  • Income Distribution: Annually
    Capital Gains Distribution: Annually
    Sales Status: Open
    Minimum Investment $: 500
    Subsequent Investment $: 25



    Performance Analysis as of  January 31, 2018

    Growth of $10,000

    Returns and Quartile Ranking
    Calendar Returns %

    Trailing Return %

    Portfolio Analysis

    Asset Mix

    Top Ten Holdings
    Top Ten Holdings % Assets
    Apple Inc 9.3
    Microsoft Corp 8.5
    Alphabet Inc A 8.1
    Facebook Inc A 5.3
    Johnson & Johnson 3.6
    UnitedHealth Group Inc 2.9
    Visa Inc Class A 2.8
    Cisco Systems Inc 2.5
    Intel Corp 2.4
    Pfizer Inc 2.3
    % Assets
    Total % of Top Ten Holdings 47.7
    Total Number of Stock Holdings 133
    Total Number of Bond Holdings 0
    Total Number of Other Holdings 3
    Total Number of Holdings 136
    Equity Style
    P/B Ratio 4.6
    P/E Ratio 21.8
    Avg. Mkt Cap. $Bil 225.6
    Global Equity Sectors
    % Equity
    Information Technology 68.0
    Health Care 31.8
    Telecommunications Services 0.1

    Please consult your advisor and read the prospectus or Fund Facts document before investing. There may be commissions, trailing commissions, management fees and expenses associated with mutual fund investments. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.